Capuozzo M - Search Results

1

Optimizing Antibiotic Use: Addressing Resistance Through Effective Strategies and Health Policies.

Capuozzo M, Zovi A, Langella R, Ottaiano A, Cascella M, Scognamiglio M, Ferrara F. Capuozzo M, et al. Antibiotics (Basel). 2024 Nov 21;13(12):1112. doi: 10.3390/antibiotics13121112. Antibiotics (Basel). 2024. PMID: 39766502 Free PMC article. Review.

2

Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance.

Ferrara F, Pasquinucci R, Capuozzo M, Polito G, Bagaglini G, Vaccaro M, Coluccia A, Langella R, Trama U, Nava E, Zovi A. Ferrara F, et al. Among authors: capuozzo m. Pharmaceuticals (Basel). 2024 Jan 30;17(2):183. doi: 10.3390/ph17020183. Pharmaceuticals (Basel). 2024. PMID: 38399398 Free PMC article.

3

Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality.

Capuozzo M, Celotto V, Zovi A, Langella R, Ferrara F. Capuozzo M, et al. Eur J Health Econ. 2024 Feb;25(1):1-5. doi: 10.1007/s10198-023-01640-4. Epub 2023 Oct 25. Eur J Health Econ. 2024. PMID: 37878195

4

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors.

Capuozzo M, Ferrara F, Santorsola M, Zovi A, Ottaiano A. Capuozzo M, et al. Cells. 2023 Nov 8;12(22):2590. doi: 10.3390/cells12222590. Cells. 2023. PMID: 37998325 Free PMC article. Review.

5

Antibacterial agents and the fight against antibiotic resistance: A real-world evidence analysis of consumption and spending by an Italian healthcare company.

Ferrara F, Capuozzo M, Pasquinucci R, Langella R, Trama U, Nava E, Zovi A. Ferrara F, et al. Among authors: capuozzo m. Ann Pharm Fr. 2024 May;82(3):545-552. doi: 10.1016/j.pharma.2024.01.001. Epub 2024 Jan 11. Ann Pharm Fr. 2024. PMID: 38218426

6

Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence.

Ferrara F, Capuozzo M, Celotto V, Ottaiano A, Langella R, Zovi A. Ferrara F, et al. Among authors: capuozzo m. Indian J Gastroenterol. 2024 Jun;43(3):645-651. doi: 10.1007/s12664-023-01501-1. Epub 2024 Jan 17. Indian J Gastroenterol. 2024. PMID: 38231298

7

Analysis of biosimilars consumption in an Italian Local Health Authority.

Ferrara F, Capuozzo M, Langella R, Trama U, Nava E, Ottaiano A, Zovi A. Ferrara F, et al. Among authors: capuozzo m. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5317-5323. doi: 10.1007/s00210-024-02951-w. Epub 2024 Jan 17. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38231416

8

The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company.

Ferrara F, Capuozzo M, Langella R, Trama U, Nava E, Zovi A. Ferrara F, et al. Among authors: capuozzo m. J Cancer Policy. 2024 Jun;40:100473. doi: 10.1016/j.jcpo.2024.100473. Epub 2024 Mar 18. J Cancer Policy. 2024. PMID: 38508413

9

Atopic dermatitis: treatment and innovations in immunotherapy.

Ferrara F, Zovi A, Capuozzo M, Langella R. Ferrara F, et al. Among authors: capuozzo m. Inflammopharmacology. 2024 Jun;32(3):1777-1789. doi: 10.1007/s10787-024-01453-8. Epub 2024 Apr 6. Inflammopharmacology. 2024. PMID: 38581639 Review.

10

Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer.

Capuozzo M, Santorsola M, Ianniello M, Ferrara F, Zovi A, Petrillo N, Castiello R, Fantuz MR, Ottaiano A, Savarese G. Capuozzo M, et al. Diseases. 2024 May 2;12(5):87. doi: 10.3390/diseases12050087. Diseases. 2024. PMID: 38785742 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters